Hybrid Treatment of an Aortic Arch Aneurysm with an Aberrant Right Subclavian Artery.
10.3904/kjm.2014.87.2.193
- Author:
Jong Hyun CHOI
1
;
Hye Yoon JANG
;
Moo Song JEON
;
Hye Won LEE
;
Jin Sup PARK
;
Sang Pil KIM
;
Han Cheol LEE
Author Information
1. Division of Cardiology, Department of Internal Medicine, Pusan National University Hospital, Pusan National University School of Medicine, Busan, Korea. glaraone@hanmail.net
- Publication Type:Case Report
- Keywords:
Aorta;
Aortic aneurysm;
Stents;
Aberrant subclavian artery
- MeSH:
Aged;
Aneurysm*;
Angiography, Digital Subtraction;
Aorta;
Aorta, Thoracic*;
Aortic Aneurysm;
Aortic Aneurysm, Thoracic;
Arm;
Arteries;
Blood Vessel Prosthesis;
Drug Therapy;
Endoleak;
Female;
Humans;
Methods;
Multiple Myeloma;
Stents;
Subclavian Artery*;
Thoracotomy
- From:Korean Journal of Medicine
2014;87(2):193-199
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
Aberrant right subclavian artery (ARSA) is a rare congenital anomaly but is the most common of the congenital vascular anomalies of the aortic arch. We report the case of a 68-year-old female undergoing chemotherapy for multiple myeloma who had a large thoracic aortic aneurysm (7.4 cm) with ARSA. She was treated with a hybrid procedure that combined a left common carotid-to-subclavian artery bypass with a "thoracic endovascular aortic repair (TEVAR)" because of the risk associated with a thoracotomy. A stent graft was deployed in the proximal part of the descending aorta to cover the thoracic aortic aneurysm after a left common carotid-to-subclavian bypass was made to restore blood flow in the left arm. There was no endoleak on digital subtraction angiography. Hybrid therapy can be performed successfully for the treatment of thoracic aortic aneurysm with ARSA.
